Showing results (881-890 of 1,211) with videos related to

Sort By:
Pageof 122
Journal of the American College of Cardiology|May 14, 2021
Kidney Function and Outcomes in Patients Hospitalized With Heart FailureRavi B Patel, Gregg C Fonarow, Stephen J Greene, et al.
JAMA Cardiology|October 13, 2021
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical TrialG Michael Felker, Scott D Solomon, Brian Claggett, et al.
European Heart Journal|January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fractionJames P Curtain, Carly Adamson, Toru Kondo, et al.
European Journal of Heart Failure|March 2, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trialYasuhiro Hamatani, Brian L Claggett, Ian J Kulac, et al.
The Lancet. Digital Health|December 5, 2021
Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort studyJasper Tromp, Paul J Seekings, Chung-Lieh Hung, et al.
European Journal of Heart Failure|May 22, 2023
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre-specified analysis of the NUDGE-FLU trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|November 17, 2024
Kidney Outcomes in Transthyretin Amyloid CardiomyopathyAdam Ioannou, Yousuf Razvi, Aldostefano Porcari, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
Respiratory Investigation|November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trialLisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 122